Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

(2020) Yi Tan et al.   Nature Reviews Cardiology

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction

(2019) Pieter Martens et al.   Clinical Research in Cardiology

Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction

(2019) James L. Januzzi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)

(2018) James L. Januzzi et al.   AMERICAN HEART JOURNAL

Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure

(2018) Abhinav Sharma et al.   Circulation-Heart Failure

Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices

(2018) Carlos de Diego et al.   HEART RHYTHM

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

(2018) Sana M. Al-Khatib et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2017) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Glycaemic control in heart failure: a PARADIGM shift for patients with concomitant diabetes?

(2017) Gregory Giamouzis et al.   Lancet Diabetes & Endocrinology

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction

(2016) Zhanna Kobalava et al.   Cardiovascular Therapeutics

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE

(2016) Søren L. Kristensen et al.   Circulation-Heart Failure

Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction

(2016) Andrew MN Walker et al.   Diabetes & Vascular Disease Research

In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry

(2016) Giovanni Targher et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes

(2016) Csaba Mátyás et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure

(2016) Isabelle Johansson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis

(2015) Hui Sun et al.   BMC Cardiovascular Disorders

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and DeathCLINICAL PERSPECTIVE

(2015) Matthew A. Cavender et al.   CIRCULATION

Concomitant Diabetes Mellitus and Heart Failure

(2015) Alessandra Dei Cas et al.   CURRENT PROBLEMS IN CARDIOLOGY

Sudden cardiac death in patients with diabetes mellitus and chronic heart failure

(2015) Andrew MN Walker et al.   Diabetes & Vascular Disease Research

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond

(2014) Robert Lukowski et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy

(2012) U. Hoke et al.   DIABETES CARE

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle

(2012) Stefan Engeli et al.   JOURNAL OF CLINICAL INVESTIGATION

Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both

(2011) Amil M. Shah et al.   AMERICAN HEART JOURNAL

Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction

(2011) Richard M. Cubbon et al.   Circulation-Heart Failure

Differential Expression of PDE5 in Failing and Nonfailing Human Myocardium

(2011) Xiaoyin Shan et al.   Circulation-Heart Failure

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans

(2008) A. L. Birkenfeld et al.   DIABETES

Increased Aldosterone Levels in a Model of Type 2 Diabetes Mellitus

(2008) S. Fredersdorf et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES